Discovery of 1,2,4-oxadiazole derivatives as a novel class of inhibitors of 3-hydroxykynurenine transaminase (HKT) from Aedes aegypti

Vol. 1, 2019 - 114141
Poster and Oral (selected)
Favorite this paper
How to cite this paper?
Abstract

Aedes aegypti mosquitoes transmit dengue and Zika fever, critical problems in Public Health. Chemical control remains an important strategy to decrease mosquito population. 3-Hydroxykynurenine transaminase (HKT) is a detoxification enzyme that converts 3-hydroxykynurenine (unstable compound) into xanthurenic acid (nontoxic molecule). 1,2,4-Oxadiazole derivatives showed larvicidal activity with evidence of inhibiting HKT in Ae. aegypti mosquitoes. Therefore, we investigated the role of HKT as molecular target of 1,2,4-oxadiazole derivatives. The cloning and expression of Aedes aegypti HKT gene and recombinant protein purification were performed in a final yield of 30 mg.L-1. To assess enzyme kinetics and inhibition profile, a fast and cheap methodology was developed based on detection of xanthurenic acid-Fe3+ complex at 570 nm. The eleven synthesized and new 1,2,4-oxadiazoles showed IC50 between 42 and 294 μM, behaving as noncompetitive inhibitors. We are now performing computational simulations to identify groups involved in enzyme-inhibitor interactions.

Institutions
  • 1 UFPE
  • 2 USP - São Carlos
  • 3 FIOCRUZ - PE
Track
  • 2. Medicinal Chemistry of Synthetic Compounds
Keywords
HKT heterologous expression
xanthurenic acid detection
larvicidal compounds
biochemical assay development